Now some researchers are fine-tuning that strategy by moving
upstream to test waste from single hospitals or other buildings,
aiming to quickly pinpoint burgeoning COVID-19 outbreaks and stop
them with testing and isolation.
While the virus primarily spreads through droplets expelled from the
mouth and nose, it can also be shed via human waste.
Testing sewage is cheaper and less invasive than swabbing hundreds
of people, and it could be done more frequently. With the virus
again surging across much of the world, schools, hospitals and care
homes badly need to catch new cases early.
"What we're trying to do is identify outbreaks before they happen,"
said Francis Hassard, a lecturer at Cranfield University, part of a
project that started collecting samples at 20 London secondary
schools last month.
Hassard's UK government-funded team will expand sampling to at least
70 schools. The program is a research project, meant to test the
approach, and is not yet a full-fledged surveillance system.
In the Canadian province of Alberta, researchers at the University
of Calgary have been gathering samples from three local hospitals,
including the site of a recent outbreak in which 12 people died.
The team was still refining their methods when that outbreak began.
When they went back to test wastewater, they found the amount of
coronavirus genetic material rose 580% as the virus spread, said
Kevin Frankowski, executive director of Advancing Canadian
Wastewater Assets.
"We saw a very significant change," said Frankowski. "It was really
strong proof that this ... approach works."
The project shares data with Alberta Health Services, which runs the
province's hospitals. If levels spike again, they could respond by
testing individuals or taking other steps to mitigate spread,
depending on the situation, said Frankowski.
In the United States, professional services company GHD set up
wastewater testing at a handful of university residences, and
recently started advertising the service to long-term care homes,
drawing significant interest, said Peter Capponi, a principal at GHD.
CLOSE TO THE SOURCE
So far, most sewage testing has been done at treatment plants. Dutch
authorities publish a national statistic, based on samples from all
over the country, and French authorities have cited similar data for
months. The state of Ohio monitors water at treatment plants across
the state.
[to top of second column] |
However, it can take 24-to-36 hours for waste to arrive at a treatment plant,
and heavy rain or industrial effluent can dilute samples.
When viral levels rise at a treatment plant, it is not always obvious what
should be done. But when virus material suddenly appears in sewage leaving a
single building, the path forward is more clear.
At the University of Arizona, for example, sewage from one residence turned
positive on August 25. The next day, the university began testing students. Two
tested positive and were isolated, heading off what could have been an outbreak,
the school said in a release.
With most of these efforts in early stages, it is not yet clear how well the
approach will work at scale.
Not every infected person sheds virus in their waste, and there is some
disagreement among researchers on how early in the course of COVID-19 that
shedding begins on average.
Human behavior can affect data collection. Do enough children use the bathroom
at school to generate good data? The virus does not show up in urine, just solid
waste.
There are also logistical issues.
"Buildings have multiple discharge points," said GHD's Capponi. "Some of them
are not accessible. Some may show up on a design drawing, but were not
constructed that way."
Outside the controlled environment of a treatment plant, sewage is less uniform.
Sampling equipment can get clogged with toilet paper and other debris, said
Hassard.
And a single "grab" sample might miss the virus. The UK project collects
throughout the school day.
Higher-tech auto-samplers can collect waste over a longer period, but are in
increasingly short supply as more testing programs ramp up.
MilliporeSigma, a unit of Germany's Merck KGaA <MRCG.DE>, makes the Centricon
P-70 filter used on some waste samples.
The company has doubled production, a spokeswoman said, after an "unprecedented
surge in demand" from governments hoping to test for the virus.
(Reporting by Allison Martell in Toronto; Edilting by Caroline Humer and Bill
Berkrot)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |